2Ajani JA,Cutsem EV,Moiseyenko V,ct al.Docetaxel(D),cisplatin,5-fluorouracil compare to cisplatin(C)and 5-fluorouracil(F)for chemotherapy-naive patients with metastatic or locally recurrent,unresectable gastric carcinoma(MGC):Interim results of a randomized phase Ⅲ trial(V325)[C].Proc ASCO,2003,Abstract 999.
3Kim DY,Kim JH,Lee SH,et al.Phase Ⅱ study of oxaliplatin,5-fluorouracil and leucovorin in previously platinum-treated patients with advanced gastric cancer [J].Ann Oncol,2003,14(3):383-387.
5Cavanna L,Berte R,Bemuzzi P,et al.Oxaliplatin,in combination with 5-fluorouracil(5-Fu)and leucovorin(LV)in patients with advanced or metastatic gastric cancer [C].Proc ASCO,2003,Abstrct 1369.
6Moiseyenko VM,Ajani JA,Tjulandin SA,et al.Final results of a randomized controlled phase Ⅲ trial(TAX 325)comparing docetaxel(T)combined with cisplatin(C)and 5-fluorouracil(F)to CF in patients(pts)with metastatic gastric adenocarcinoma(MG C)[C].Proc ASCO,2005 ,Abstract 4002.
7Elsaid AA,Elkerm Y.Final results of a randomized phase Ⅲ trial of Docetaxel,Carboplatin and 5FU versus Epirubicin,cisplatin and 5FU for locally advanced gastric cancer [C].Proc ASCO,2005,Abstract 4014.
8Dank M,Zaluski J,Barone C,et al.Randomized phase 3 trial of irinotecan(CPT-11)+5FU/folinic acid(FA)vs CDDP +5FU in 1st-line advanced gastric cancer patients [C].Proc ASCO,2005,Abstract 4003.
二级参考文献31
1[1]Ajani JA.Treatment of patients with upper gastrointestinal carcinomas[J]. Semin Oncol, 1997,24(6 Suppl 19):1972-1987.
2[2]Ilson DH, Ajani J, Bhalla K, et al. Phase Ⅱ trial of paclitaxel, fluorouracil and cisplatin in patients with advanced carcinoma of the esophagus[J]. J Clin Oncol,1998,16(5):1826-1834.
3[3]Petrasch S, Welt A, Reinacher A, et al. Chemotherapy with cisplatin and paclitaxel in patients with locally advanced,recurrent or metastatic esophageal cancer[J]. Br J Cancer,1998,78(4):511-517.
4[4]Kelsen D, Ginsberg R, Bains M, et al. A phase Ⅱ trial of paclitaxel and cisplatin in patients with locally advanced metastatic esophageal cancer: a preliminary report[J]. Semin Oncol,1997,24(6 Suppl 19):1977-1989.
5[5]Safran H, Akerman P, Cioffi W, et al. Paclitaxel and concurrent radiation therapy for locally advanced adenocarcinomas of the pancreas,stomach and gastroesophageal junction[J]. Semin Radiat Oncol,1999,9(2 Suppl 1):53-64.
6[6]Meluch AA, Hainsworth JD, Gray JR, et al. Preoperative combined modality therapy with paclitaxel, carboplatin,prolonged infusion 5_fluorouracil, and radiation therapy in localized esophageal cancer:preliminary results of a Minnie Pearl Cancer Research Network phase Ⅱ trial[J]. Cancer J Sci Am,1999,5(2):84-93.
7[7]Ajani JA, Fairweather J, Dumas P, et al. Phase Ⅱ study of Taxol in patients with advanced gastric carcinoma[J]. Cancer J Sci Am,1998,4(4):269-276.
8[8]Cascinu S, Graziano F, Cardarelli N, et al. Phase Ⅱ study of paclitaxel in pretreated advanced gastric cancer[J]. Anticancer Drugs,1998,9(4):307-312.
9[9]urad AM, Petroianu A, Guimaraes RC, et al. Phase Ⅱ trial of the combination of paclitaxel and 5-fluorouracil in the treatment of advanced gastric cancer: a novel, safe, and effective regimen[J]. Am J Clin Oncol,1999, 22(6):580-591.
10[10]Kim YH, Shin SW, Kim BS, et al. Paclitaxel,5_fluorouracil and cisplatin combination chemotherapy for the treatment of advanced gastric carcinoma[J].Cancer,1999,85(2):295-302.
